Markus Aebi

Markus Aebi

Auto-generated profile, based on publicly available information

Markus Aebi

Institute of Microbiology, Department of Biology, ETH Zurich, 8093 Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2013 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
MAMarkus Aebi
Markus Aebi

1 February 2010 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
MAMarkus Aebi
Markus Aebi
RBRiccardo Bernasconi
Riccardo Bernasconi
SCSimone Clerc
Simone Clerc
MMMaurizio Molinari
Maurizio Molinari

10 June 2013 in Cold Spring Harbor Perspectives in Biology
Verified
Journal Article
Open access
PDF file
JBJörg Breitling
Jörg Breitling
MAMarkus Aebi
Markus Aebi
The attachment of glycans to asparagine residues of proteins is an abundant and highly conserved essential modification in eukaryotes. The N-glycosylation process includes two principal phases: the assembly of a lipid-linked oligosaccharide (LLO) and the transfer of the oligosaccharide to selected asparagine residues of polypeptide chains. Biosynthesis of the LLO takes place at both sides of the endoplasmic reticulum (ER) membrane and it involves a series of specific glycosyltransferases that catalyze the assembly of the branched oligosaccharide in a highly defined way. Oligosaccharyltransferase (OST) selects the Asn-X-Ser/Thr consensus sequence on polypeptide chains and generates the N-glycosidic linkage between the side-chain amide of asparagine and the oligosaccharide. This ER-localized pathway results in a systemic modification of the proteome, the basis for the Golgi-catalyzed modification of the N-linked glycans, generating the large diversity of N-glycoproteome in eukaryotic cells. This article focuses on the processes in the ER. Based on the highly conserved nature of this pathway we concentrate on the mechanisms in the eukaryotic model organism Saccharomyces cerevisiae.

4 February 2005 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
DLDennis Linton
Dennis Linton
NDNick Dorrell
Nick Dorrell
PHPaul G. Hitchen
Paul G. Hitchen
SASaba Amber
Saba Amber
Andrey V. KarlyshevAndrey V. Karlyshev
Andrey V. Karlyshev
BWBrendan W Wren
Brendan W Wren
Summary: We describe in this report the characterization of the recently discovered N‐linked glycosylation locus of the human bacterial pathogen Campylobacter jejuni, the first such system found in a species from the domain Bacteria. We exploited the ability of this locus to function in Escherichia coli to demonstrate through mutational and structural analyses that variant glycan structures can be transferred onto protein indicating the relaxed specificity of the putative oligosaccharyltransferase PglB. Structural data derived from these variant glycans allowed us to infer the role of five individual glycosyltransferases in the biosynthesis of the N‐linked heptasaccharide. Furthermore, we show that C. jejuni‐ and E. coli‐derived pathways can interact in the biosynthesis of N‐linked glycoproteins. In particular, the E. coli encoded WecA protein, a UDP‐GlcNAc: undecaprenylphosphate GlcNAc‐1‐phosphate transferase involved in glycolipid biosynthesis, provides for an alternative N‐linked heptasaccharide biosynthetic pathway bypassing the requirement for the C. jejuni‐derived glycosyltransferase PglC. This is the first experimental evidence that biosynthesis of the N‐linked glycan occurs on a lipid‐linked precursor prior to transfer onto protein. These findings provide a framework for understanding the process of N‐linked protein glycosylation in Bacteria and for devising strategies to exploit this system for glycoengineering.

2 February 2018 in Science
Verified
Journal Article
Closed access
PDF file
RWRebekka Wild
Rebekka Wild
JKJulia Kowal
Julia Kowal
JEJillianne Eyring
Jillianne Eyring
ENElsy M. Ngwa
Elsy M. Ngwa
MAMarkus Aebi
Markus Aebi
KLKaspar P. Locher
Kaspar P. Locher
Remember the sugar when making proteins: Eukaryotes have an elaborate trafficking and quality-control system for secreted glycoproteins. The glycosylation pathway begins in the endoplasmic reticulum with the enzyme oligosaccharyltransferase (OST), which attaches a long chain of sugars to asparagine residues of target proteins. Wild et al. report a cryo-electron microscopy structure of yeast OST, which includes eight separate membrane proteins. The central catalytic subunit contains binding sites for substrates and is flanked by accessory subunits that may facilitate delivery of newly translocated proteins for glycosylation. Science , this issue p. 545

1 December 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
AEAndreas Essig
Andreas Essig
DHDaniela Hofmann
Daniela Hofmann
DMDaniela Münch
Daniela Münch
SGSavitha Gayathri
Savitha Gayathri
MKMarkus Künzler
Markus Künzler
MAMarkus Aebi
Markus Aebi
Fungi and bacteria compete with an arsenal of secreted molecules for their ecological niche. This repertoire represents a rich and inexhaustible source for antibiotics and fungicides. Antimicrobial peptides are an emerging class of fungal defense molecules that are promising candidates for pharmaceutical applications. Based on a co-cultivation system, we studied the interaction of the coprophilous basidiomycete Coprinopsis cinerea with different bacterial species and identified a novel defensin, copsin. The polypeptide was recombinantly produced in Pichia pastoris, and the three-dimensional structure was solved by NMR. The cysteine stabilized α/β-fold with a unique disulfide connectivity, and an N-terminal pyroglutamate rendered copsin extremely stable against high temperatures and protease digestion. Copsin was bactericidal against a diversity of Gram-positive bacteria, including human pathogens such as Enterococcus faecium and Listeria monocytogenes. Characterization of the antibacterial activity revealed that copsin bound specifically to the peptidoglycan precursor lipid II and therefore interfered with the cell wall biosynthesis. In particular, and unlike lantibiotics and other defensins, the third position of the lipid II pentapeptide is essential for effective copsin binding. The unique structural properties of copsin make it a possible scaffold for new antibiotics.